3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
1
Anemia
1
Interventions
fludarabine phosphate
15
Whole-Body Irradiation
9
Peripheral Blood Stem Cell Transplantation
8
Mycophenolic Acid
8
Cyclosporine
8
Cyclophosphamide
7
Tacrolimus
5
Filgrastim
5
Cytarabine
5
Carboplatin
4
Azacitidine
4
olaparib
3
Thiotepa
3
Lenalidomide
3
Etoposide
3
Bortezomib
3
Biopsy
3
Antilymphocyte Serum
3
venetoclax
2
tipifarnib
2
sargramostim
2
peginesatide
2
laromustine
2
hematide
2
enasidenib
2
alvocidib
2
aldesleukin
2
Vorinostat
2
Tretinoin
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
iron isomaltoside 1000
×
Classical hematology
×
Clear all
NCT01280240
2013-06-04
PK-CIA-06
Pharmacosmos A/S
Phase 1
Completed
11 enrolled